Literature DB >> 21472306

Microsomal epoxide hydrolase polymorphisms.

Hatice Pinarbasi1, Yavuz Silig, Ergun Pinarbasi.   

Abstract

Microsomal epoxide hydrolase plays a dual role in the activation and detoxification of carcinogenic compounds. Two polymorphic sites have been described in exons 3 and 4 of the microsomal epoxide hydrolase gene that change tyrosine residue 113 to histidine (Tyr113His) and histidine 139 to arginine (His139Arg), respectively. The exon 3 polymorphism reduces enzyme activity by approximately 50%, whereas the exon 4 polymorphism causes a 25% increase in activity. In the present study, the distribution of these polymorphisms in a Turkish population including 625 unrelated healthy individuals was examined using a PCR-RFLP method. The observed genotype frequencies of microsomal epoxide hydrolase exon 3 were 54, 38 and 8% for Tyr113Tyr, Tyr113His and His113His, respectively. Exon 4 genotype frequencies were found to be 69, 29 and 2% for His139His, His139Arg and Arg139Arg, respectively.

Entities:  

Year:  2010        PMID: 21472306     DOI: 10.3892/mmr_00000324

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Chen-Yang Duan; Meng-Ying Liu; Shao-bo Li; Kuan-sheng Ma; Ping Bie
Journal:  Tumour Biol       Date:  2013-08-17

2.  Association between environmental tobacco smoke exposure and lung cancer susceptibility: modification by antioxidant enzyme genetic polymorphisms.

Authors:  Mona Fathy; Mai Hamed; Omnia Youssif; Nahla Fawzy; Wafa Ashour
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

3.  In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.

Authors:  Zhican Wang; Ying Fang; Juli Teague; Hansen Wong; Christophe Morisseau; Bruce D Hammock; Dan A Rock; Zhengping Wang
Journal:  Drug Metab Dispos       Date:  2017-04-20       Impact factor: 3.922

4.  Missense Genetic Polymorphisms of Microsomal (EPHX1) and Soluble Epoxide Hydrolase (EPHX2) and Their Relation to the Risk of Large Artery Atherosclerotic Ischemic Stroke in a Turkish Population.

Authors:  Birsen Can Demirdöğen; Yağmur Miçooğulları; Aysun Türkanoğlu Özçelik; Orhan Adalı
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-07       Impact factor: 2.570

5.  mEH Tyr113His polymorphism and the risk of ovarian cancer development.

Authors:  Jian-Hong Zhong; Zhi-Ming Zhang; Le-Qun Li
Journal:  J Ovarian Res       Date:  2013-06-06       Impact factor: 4.234

6.  Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects.

Authors:  Natalia Guevara; Cecilia Maldonado; Manuel Uría; Raquel González; Manuel Ibarra; Silvana Alvariza; Antonella Carozzi; Carlos Azambuja; Pietro Fagiolino; Marta Vázquez
Journal:  Pharmaceuticals (Basel)       Date:  2017-08-18

7.  Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Bang-De Xiang; Liang Ma; Xue-Mei You; Le-Qun Li; Gui-Sheng Xie
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

8.  Lamotrigine-Valproic Acid Interaction Leading to Stevens-Johnson Syndrome.

Authors:  Marta Vázquez; Cecilia Maldonado; Natalia Guevara; Andrea Rey; Pietro Fagiolino; Antonella Carozzi; Carlos Azambuja
Journal:  Case Rep Med       Date:  2018-08-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.